Verification of Colorectal Cancer Recurrence Prediction and Screening Capability Through Methylation Analysis of DNA in Plasma of SETOCHI Study Participants

Verification of Colorectal Cancer Recurrence Prediction and Screening Capability Through Methylation Analysis of DNA in Plasma of SETOCHI Study Participants - SETOUCHI-Liquid Biopsy Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053122

Enrollment

452

Registered

2023-12-15

Start date

2023-12-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Targeting participants who participated in the SETOUCHI Study.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Verification of the effectiveness of recurrence prediction and early screening after curative resection, based on analysis results from Hi-SA method (Fragment Assay), DNA Chip (Gene Silicon), dPCR (QuantStudio Absolute Q Digital PCR System), and real-time PCR.	—

Secondary

Measure	Time frame
1) Setting the cutoff values in Hi-SA method (Fragment Assay), DNA Chip (Gene Silicon), dPCR (QuantStudio Absolute Q Digital PCR System), and real-time PCR. 2) Elucidation of the interrelationships in the results of Hi-SA method (Fragment Assay), DNA Chip (Gene Silicon), dPCR (QuantStudio Absolute Q Digital PCR System), and real-time PCR.	—

Countries

Japan

Contacts

Public ContactTakeshi Nagasaka

Kawasaki Medical School Advanced Oncology

takeshin@med.kawasaki-m.ac.jp0864621111

Outcome results